Chrysos Corporation (ASX:C79) has disclosed unaudited revenue of $36.7 million for the four months from July to October in FY27, representing a 27% increase on the prior corresponding period, ahead of its Annual General Meeting scheduled for 25 November 2026.
Key Points
- FY27 July–October revenue of $36.7m comprised $22.6m in Minimum Monthly Assay Payments, $13.7m in Additional Assay Charges and $0.3m in other revenue
- 4.91 million samples were processed during the period, a 43% increase on the prior corresponding period, with October 2026 a record of 1.36 million samples in a single month
- 15 new PhotonAssay™ lease agreements signed so far in FY27, bringing total contracted units to 97
- Deployed PhotonAssay fleet totals 51 units across five continents, with six units currently being deployed
- Company held cash of $19.5m with $80.0m drawn and $120.0m undrawn under its $200m syndicated facility as at 31 October 2026
FY27 Revenue and Sample Processing Details
According to the filing, unaudited revenue for the July to October FY27 period totalled $36.7 million, up 27% on the prior corresponding period. The revenue comprised $22.6 million in Minimum Monthly Assay Payments, $13.7 million in Additional Assay Charges, and $0.3 million in other revenue. A total of 4.91 million samples were processed during the period, a 43% increase on the prior corresponding period. October 2026 was disclosed as a record month, with 1.36 million samples processed in a single month.
New Lease Agreements and Unit Deployments
The company disclosed that 15 new PhotonAssay™ lease agreements have been signed so far in FY27, including 11 new contracts signed since Chrysos' August release. Those 11 agreements comprise two direct-to-miner lease agreements, four units with SGS including one mine-site unit, four units with ALS, and one unit with Alfred H Knight. Six units have been deployed during FY27, with locations including BV in Kalgoorlie, Australia; ALS in Rouyn Noranda and Surrey, Canada; Aurenne at Mt Ida Gold Mine, Australia; and MSA in Paramaribo, Suriname and Korhogo, Ivory Coast. The total deployed fleet now stands at 51 units across five continents.
FY27 Full-Year Guidance Reaffirmed and Balance Sheet Position
Chrysos reaffirmed its FY27 guidance on a constant currency basis, unchanged from the FY26 results announcement of 11 August 2026. The company guided for revenue of $108 million to $118 million and EBITDA of $35 million to $42 million. As at 31 October 2026, the company held cash of $19.5 million, with $80.0 million drawn and $120.0 million undrawn under its $200 million syndicated facility, which the filing states provides funding to support the deployment of contracted units.




Please wait processing your request...